|
|
Volumn 14, Issue 4, 1999, Pages 239-243
|
|
Anti-dementia drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
METRIFONATE;
RIVASTIGMINE;
TACRINE;
AGED;
ALZHEIMER DISEASE;
COGNITION;
DEMENTIA;
EDITORIAL;
HUMAN;
ACTIVITIES OF DAILY LIVING;
AGED;
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
CLINICAL TRIALS;
COGNITION DISORDERS;
COST-BENEFIT ANALYSIS;
FEMALE;
GREAT BRITAIN;
GUIDELINES;
HUMANS;
MALE;
MIDDLE AGED;
|
|
EID: 0032921635
PISSN: 08856230
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1099-1166(199904)14:4<239::AID-GPS918>3.0.CO;2-7 Document Type: Editorial |
|
Times cited : (19)
|
|
References (23)
|
